743626
Last Update Posted: 2018-02-22
Recruiting has ended
Females accepted | 18 Years + |
1712 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Pap Smear Research Study
The principal hypothesis of this study is that HPV testing and/or p16 testing, either alone or in combination or associated with a Pap smear, will demonstrate greater specificity for clinically significant precancerous disease than will a Pap smear alone and that these tests will be of comparable or superior sensitivity than the Pap smear.
Eligibility
Relevant conditions:
Cervical Cancer
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov